SALOFALK GRANULES mesalazine 500mg modified release granules sachet ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

salofalk granules mesalazine 500mg modified release granules sachet

dr falk pharma australia pty ltd - mesalazine, quantity: 500 mg - granules, modified release - excipient ingredients: colloidal anhydrous silica; purified talc; povidone; aspartame; titanium dioxide; methacrylic acid copolymer; magnesium stearate; triethyl citrate; microcrystalline cellulose; carmellose sodium; simethicone; citric acid; hypromellose; flavour - salofalk granules are indicated for the treatment of acute ulcerative colitis of mild to moderate severity, and for the maintenance of remission and/or the long term treatment of ulcerative colitis.